Cargando…
Polymyalgia rheumatica and cancer: surveillance duration and other points to ponder
Autores principales: | Manzo, Ciro, Nune, Arvind |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10044035/ https://www.ncbi.nlm.nih.gov/pubmed/36998582 http://dx.doi.org/10.5114/reum.2023.124336 |
Ejemplares similares
-
Is the absence of prolonged morning stiffness at the time of diagnosis of polymyalgia rheumatica a paraneoplastic warning?
por: Manzo, Ciro, et al.
Publicado: (2022) -
Polymyalgia rheumatica and polymyalgia-like syndromes as adverse events following immunisation with COVID-19 vaccines: a 15 months update
por: Manzo, Ciro, et al.
Publicado: (2023) -
Messages from the history of polymyalgia rheumatica
por: Manzo, Ciro
Publicado: (2021) -
Back to the future: identification and classification of polymyalgia rheumatica and polymyalgia rheumatica-like syndromes following cancer immunotherapy with checkpoint inhibitors
por: Manzo, Ciro, et al.
Publicado: (2021) -
Polymyalgia rheumatica and cancer risk: the importance of the diagnostic set
por: Manzo, Ciro, et al.
Publicado: (2016)